EUVIMEDEUVIMED entdecken
Crossref

Poly(ADP-ribose) polymerase (PARP)-targeted PET imaging in non-oncology application: a pilot study in preclinical models of nonalcoholic steatohepatitis

Troels E Jeppesen

American Journal of Nuclear Medicine and Molecular Imaging · 2024 · 14 (1) · 41-47

DOI: 10.62347/wtkq3953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Troels E Jeppesen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ga]-DOTA-PARPi did not reveal a significantly higher uptake in NASH models compared to the control. This underscores the necessity for further development of new chelator-based PARP1 tracers with high binding affinity to enable the visualization of PARP1 changes in NASH pathology.

Zitieren

APA

Jeppesen, T. E. (2024). Poly(ADP-ribose) polymerase (PARP)-targeted PET imaging in non-oncology application: a pilot study in preclinical models of nonalcoholic steatohepatitis. American Journal of Nuclear Medicine and Molecular Imaging, 14(1), 41-47. https://doi.org/10.62347/wtkq3953

Vancouver

Jeppesen TE. Poly(ADP-ribose) polymerase (PARP)-targeted PET imaging in non-oncology application: a pilot study in preclinical models of nonalcoholic steatohepatitis. American Journal of Nuclear Medicine and Molecular Imaging. 2024;14(1):41-47. doi:10.62347/wtkq3953

BibTeX
@article{Jeppesen2024,
  author = {Jeppesen, Troels E},
  title = {Poly(ADP-ribose) polymerase (PARP)-targeted PET imaging in non-oncology application: a pilot study in preclinical models of nonalcoholic steatohepatitis},
  journal = {American Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {41--47},
  doi = {10.62347/wtkq3953}
}
Kostenlos starten →